European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

European equities traded in the US as American depositary receipts were lower late Thursday morning, declining 0.56% to 1,718.19 on the S&P Europe Select ADR Index, which is still up 0.2% for the week so far.

From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and pharmaceutical company Novo Nordisk (NVO), which rose 4.2% and 2.6%, respectively. They were followed by internet advertising firm Criteo (CRTO) and internet browser company Opera (OPRA), which were up 2.1% and 1.8%, respectively.

The decliners from continental Europe were led by lender Banco Santander (SAN) and biopharmaceutical company Cellectis (CLLS), which dropped 1.6% and 1.2%, respectively. They were followed by lenders Banco Bilbao Vizcaya Argentaria (BBVA) and ING Groep (ING), which were off 0.9% and 0.4%, respectively.

The gainers from the UK were led by biopharmaceutical company Akari Therapeutics (AKTX) and software firm Endava (DAVA), which advanced 3.2% and 3.1%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and biotech firm Trinity Biotech (TRIB), which increased 2.3% and 1.8%, respectively.

The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics (SLN) and lender Lloyds Banking Group (LYG), which lost 4.9% and 1.5%, respectively. They were followed by lender Barclays (BCS) and utilities company National Grid (NGG), which were down 1.4% each.